PubChem compound: 105102

Active ingredient description

Ulinastatin is a serine protease inhibitor that reduces the pro-inflammatory response as a result of sepsis, acute pancreatitis, trauma or surgery. It inhibits coagulation and fibrinolysis and promotes microperfusion. Thus, ulinastatin is an effective agent for immune modulation to prevent organ dysfunction and promote homeostasis.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
B02AB05 B Blood and blood forming organs → B02 Antihemorrhagics → B02A Antifibrinolytics → B02AB Proteinase inhibitors
Discover more medicines within B02AB05

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
U-TRYP Solution for injection Web Search MPI, Generic

External identifiers

CAS Substance: 80449-31-6
DrugBank Drug: DB12038
KEGG Drug: D05183
PubChem Compound: 105102
UNII Identifier: OR3S9IF86U


Ulinastatin is an active ingredient of these brands:

Japan (JP)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.